| Financial Year |
March 31 2023 |
| Monetary Funds |
991,276,409.17 |
| Held-for-trading Financial Assets |
158,685,088.49 |
| Notes Receivable |
34,731,566.60 |
| Accounts Receivable |
266,098,355.95 |
| Advances to Suppliers |
190,285,394.25 |
| Other Receivables |
17,526,427.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
132,348,629.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,257,741.33 |
| Total Current Assets |
2,181,833,438.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
52,058,863.96 |
| Investment Properties |
371,843,858.24 |
| Fixed Assetes |
69,240,512.73 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,605,752.85 |
| R&D expenses |
35,498,620.45 |
| Goodwill |
41,456,283.18 |
| Long-Term Deferred and Prepaid Expenses |
3,476,806.34 |
| Deferred Income Tax Assets |
12,495,575.67 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
758,132,251.72 |
| Total Assets |
2,939,965,689.73 |
| Short-Term Loans |
24,284,007.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,556,150.00 |
| Accounts Payable |
165,449,197.12 |
| Accounts Received In Advance |
1,994,633.21 |
| Employee Compensation Payable |
83,934,439.74 |
| Taxes Payable |
53,960,843.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
24,033,914.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
25,498,515.11 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
483,175,924.43 |
| Long-term Loans |
28,525,707.56 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,434,220.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
40,659,256.75 |
| Total Liabilities |
523,835,181.18 |
| Paid-In Capital(Or Share Stock) |
444,011,100.00 |
| Capital Surplus |
933,343,113.85 |
| Surplus Reserve |
93,310,293.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
854,715,576.14 |
| Minority Stockholder's Interest |
75,704,123.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,340,426,385.03 |
| Owner's Equity（Stockholder's Equity） |
2,416,130,508.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,939,965,689.73 |
